Table 4.
Variable | NASH patients (n= 129) | Non-NASH patients (n= 775) | P-value |
---|---|---|---|
Total deaths, n (%) | 21 (16%) | 167 (22%) | 0.16 |
Aetiology of deatha, n (%) | 0.05 | ||
Infection | 8 (38%) | 43 (26%) | |
Cardiac event | 4 (19%) | 12 (7%) | |
Malignant (non-HCC) | 2 (10%) | 20 (12%) | |
Recurrent HCC | 2 (10%) | 12 (7%) | |
Pulmonary | 0 | 1 (1%) | |
Recurrent hepatitis C | 0 | 19 (11%) | |
Chronic rejection/graft failure | 0 | 14 (8%) | |
Neurologic cause | 1 (5%) | 12 (7%) | |
Renal failure | 1 (5%) | 8 (5%) | |
Postoperative complications | 1 (5%) | 8 (5%) | |
Other | 2 (10%) | 2 (1%) | |
Unknown | 0 | 16 (10%) |
Only three aetiology of death categories were analysed to reduce the risk for type I error: infection; cardiac event, and all other causes.
HCC, hepatocellular carcinoma.